Clinical Research Directory
Browse clinical research sites, groups, and studies.
Short-term Intravenous Iron Isomaltose Anhydride for IDA
Sponsor: West China Hospital
Summary
This prospective, randomized, controlled study aims to evaluate the impact of short-term intravenous iron isomaltose anhydride on postoperative recovery and the requirement for allogeneic red blood cells (RBC) transfusion in preoperative Iron-deficiency anemia (IDA) patients receiving orthopedic surgery, thus facilitating developing a simple and effective iron supplement approach for patients' recovery.
Official title: Short-term Use of Intravenous Iron Isomaltose Anhydride for Preoperative Anemic Patients Undergoing Orthopedic Surgery: a Prospective, Randomized, Controlled Study
Key Details
Gender
All
Age Range
14 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
1600
Start Date
2024-07-05
Completion Date
2029-05-31
Last Updated
2024-05-06
Healthy Volunteers
No
Conditions
Interventions
Intravenous iron isomaltose anhydride
Enrolled subjects would receive intravenous iron isomaltose anhydride within 24 hours of the subject's inclusion.